ACTHERA THERAPEUTICS
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
ACTHERA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2019-10-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.acthera-therapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
7.6 M CHF
Technology used in webpage:
Euro Swiss Server Location
Similar Organizations
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Hyris
Hyris is offers an integrated platform for decentralized nucleic acid testing Products.
Kinarus Therapeutics (SIX:KNRS)
Kinarus is focused on developing novel treatments for patients suffering from serious viral, respiratory, and ophthalmic diseases.
Latch Medical
Latch Medical reimagining the potential of drugs and vaccines.
Novasenta
Novasenta develops treatments to transform the lives of patients with cancer.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
IMD Startup Competition
IMD Startup Competition investment in Grant - Acthera Therapeutics
Official Site Inspections
http://www.acthera-therapeutics.com
- Host name: 172.67.147.168
- IP address: 172.67.147.168
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Acthera Therapeutics"
Acthera Therapeutics Company Profile 2024: Valuation, Funding ...
Acthera Therapeutics is headquartered in Basel, Switzerland. What is the size of Acthera Therapeutics? Acthera Therapeutics has 3 total employees. What industry is Acthera …See details»
Acthera Therapeutics Ltd. - LinkedIn
Acthera Therapeutics Ltd. | 1,411 followers on LinkedIn. ACTHERA is currently in liquidation, and was a Swiss biotech company founded in 2019. The team was developing a therapeutic platform based ...See details»
Acthera Therapeutics Ltd - BIO International Convention | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... Acthera Therapeutics is a …See details»
Acthera Therapeutics AG - startup.ch
Acthera Therapeutics AG: Today, patients are exposed to unwanted side effects of drugs. With the use of our technology, we can control and target the delivery of drugs with an adaptable and versatile system built around the Hard-Shelled …See details»
Acthera Therapeutics - Funding, Financials, Valuation & Investors
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery. Search Crunchbase. Start Free Trial . ... How much …See details»
Acthera Therapeutics AG - VentureRadar
Website: https://acthera-therapeutics.com. Develops mechano-responsive hard-shelled liposomes for targeted, controlled delivery of therapeutic agents, improving efficacy, safety, and efficiency …See details»
Acthera Therapeutics AG – Swiss Biotech
ACTHERA is a Swiss biotech company and is the result of over 10 years of academic research & development in the universities of Basel, Fribourg and Texas Dallas (USA). The therapeutic …See details»
Acthera Therapeutics - Products, Competitors, Financials, …
Acthera Therapeutics is a biopharmaceutical company that focuses on the development of nanoparticle-based technology for targeted and controlled drug delivery. The company's main …See details»
Acthera – Unleashing the Power of Mechanosensitive …
Mar 18, 2022 To fully unleash the power of mechanosensitive, actuated therapeutics, the biotech start-up Acthera Therapeutics Ltd. was launched in Fall 2019. The company unites talents from the field of basic and applied liposome …See details»
45 % of oncology patients suffer fromsevere drug toxicities 5 % of ...
Acthera Therapeutics is a preclinical-stage biopharma-ceutical company. It develops hard-shelled liposomes, a nanoparticle-based technology for the targeted and ... Acthera’s Hard-Shelled …See details»
Acthera receives CHF 5.4 million to advance hard-shelled liposome ...
Jul 23, 2021 Acthera Therapeutics AG, a biopharmaceutical company developing an innovative targeted release technology platform, announced today the successful completion of a CHF …See details»
Acthera Therapeutics - Contacts, Employees, Board Members
Acthera Therapeutics has 9 current employee profiles, including CEO Thierry Fumeaux. Acthera Therapeutics has 4 board members and advisors, including Roger Meier . ContactsSee details»
Acthera Therapeutics Ltd at the Swiss Biotech Day
Acthera Therapeutics is developing a unique type of mechano-sensitive Hard-Shelled Liposomes (HSL), based on a patented synthetic lipid. The HSL release their payload when submitted to a …See details»
Acthera Therapeutics raises CHF 5.4 million seed capital
Feb 7, 2021 Founded in 2019, Acthera Therapeutics addresses one of the most important challenges in medicine, optimizing the therapeutic effect while minimizing the side effects. …See details»
ACTHERA Tx closes Seed A financing and strengthens team to …
Jul 6, 2021 Acthera Therapeutics AG, a biopharmaceutical company developing an innovative targeted release technology platform, announced today the successful completion of a CHF …See details»
Meet Acthera co-CEO and CSO Pierre-Alain Monnard and discover …
May 10, 2021 Pierre-Alain Monnard and his team at Venture Leader Biotech Acthera develop Hard-Shelled Liposomes (HSLs) that enable transformative therapeutic approaches. By …See details»
Acthera Therapeutics AG - VentureRadar
Website: https://acthera-therapeutics.com. Develops mechano-responsive hard-shelled liposomes for targeted, controlled delivery of therapeutic agents, improving efficacy, safety, and efficiency …See details»
Seed Round - Acthera Therapeutics - 2021-07-02 - Crunchbase
Jul 2, 2021 Organization Name . Acthera Therapeutics . Announced Date Jul 2, 2021; Funding Type Seed; Funding Stage Seed; Money Raised . obfuscated. ... Recent News. Edit Recent …See details»
Automated Release Testing System (ARTS) (ARTS) | ZHAW Zurich …
Acthera Therapeutics AG. Project status. completed, 10/2021 - 09/2023. Funding partner. Innovationsprojekt / Projekt Nr. 56587.1 IP-LS. Project budget. 448'584 CHF. Prof. Dr. Rudolf …See details»